ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,698Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1571

$4.92M Total Retail Price of All Prescriptions

Rank: 1 out of 1571

332 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

29% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 3,825 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$359 was the average price of a prescription from this provider, compared to $99 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NORVIR 616 78 1 186
ISENTRESS 577 40 2 220
TRUVADA 559 74 3 197
ACYCLOVIR 558 101 10 4 243
ATORVASTATIN CALCIUM 482 205 5 8
EPZICOM 422 77 10 6 269
PREZISTA 369 47 7 244
LISINOPRIL 366 189 8 5
OMEPRAZOLE 259 107 9 4
INTELENCE 257 0 10 10 335
VIREAD 228 27 11 273
REYATAZ 206 45 12 325
PRAVASTATIN SODIUM 199 33 13 26
ANDROGEL 181 60 S3 14 310
AMLODIPINE BESYLATE 172 97 15 2
CITALOPRAM HBR 167 47 16 66
VIRAMUNE XR 158 29 10 17 438
GABAPENTIN 156 34 18 12
SUSTIVA 154 23 19 482
HYDROCODONE-ACETAMINOPHEN 149 37 S3 20 3
TESTOSTERONE CYPIONATE 149 21 S3 20 455
ZOLPIDEM TARTRATE 147 56 22 20
SULFAMETHOXAZOLE-TRIMETHOPRIM 144 0 23 86
PANTOPRAZOLE SODIUM 131 47 24 23
TAMSULOSIN HCL 125 37 25 11
HYDROCHLOROTHIAZIDE 118 72 26 18
WARFARIN SODIUM 116 64 27 14
TRAZODONE HCL 107 31 28 74
LEVOTHYROXINE SODIUM 105 57 29 6
SELZENTRY 102 11 30 432
LEXIVA 101 0 31 541
METFORMIN HCL ER 101 53 31 108
SIMVASTATIN 97 62 33 1
BUPROPION HCL SR 95 25 34 247
BUPROPION XL 91 19 35 183
METFORMIN HCL 90 58 36 9
LOSARTAN POTASSIUM 89 41 37 17
VALACYCLOVIR 88 0 38 366
KALETRA 88 0 38 487
CRESTOR 86 19 40 25
METOPROLOL SUCCINATE 84 33 41 16
LIPITOR 84 23 41 67
ATRIPLA 82 26 43 454
VENLAFAXINE HCL ER 78 0 44 204
ATENOLOL 71 50 45 15
ALLOPURINOL 68 40 46 36
RANITIDINE HCL 68 14 46 85
SERTRALINE HCL 66 52 48 52
LAMIVUDINE 65 20 49 490
EMTRIVA 65 18 49 480
MIRTAZAPINE 64 34 51 96
NASONEX 64 0 51 163
OXYCONTIN 60 0 S2 53 211
CYMBALTA 57 16 54 68
FAMOTIDINE 56 12 55 54
NEXIUM 56 19 55 39
CARVEDILOL 56 31 55 10
PROPRANOLOL HCL 55 0 58 176
ZIAGEN 53 0 59 508
PROAIR HFA 51 13 60 63
TRICOR 51 16 60 264
DIPHENOXYLATE-ATROPINE 50 0 62 361
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.